• 1
    Yang J, Scholten T. Dientamoeba fragilis: a review with notes on its epidemiology, pathogenicity, mode of transmission and diagnosis. Am J Trop Med Hyg 1977; 26: 1622.
  • 2
    Turner JA. Giardiasis and infections with Dientamoeba fragilis. Ped Clin North Am 1985; 32: 86580.
  • 3
    Spencer MJ, Garcia LS, Chapin MR. Dientamoeba fragilis, an intestinal pathogen in children? Am J Dis Child 1979; 133: 3903.
  • 4
    Spencer MJ, Chapin MR, Garcia LS. Dientamoeba fragilis: a gastrointestinal protozoan infection in adults. Am J Gastroenterol 1982; 77: 5659.
  • 5
    Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 1996; 51: 62138.
  • 6
    Dupouy-Camet J. Single dose treatments in tropical infectious diarrhoea. The place of secnidazole. Drug Invest 1994; 8(suppl 1): 3546.
  • 7
    Garcia LS, Bruckner DA. Diagnostic medical parasitology, 2nd edn. Washington, DC: American Society for Microbiology, 1993.
  • 8
    Millet VE, Spencer MJ, Chapin MR et al. Intestinal protozoan infection in a semicommunal group. Am J Trop Med Hyg 1983; 32: 5460.
  • 9
    Windsor JJ, Rafay AM, Shenoy AK et al. Incidence of Dientamoeba fragilis in faecal samples, submitted for routine microbiological analysis. Br J Biomed Sci 1998; 55: 1725.
  • 10
    Oyofa BA, Perusky LF, Ismail TF et al. Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria. Egypt Mil Med 1997; 162: 396400.